choline and deoxycytidine

choline has been researched along with deoxycytidine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kopper, L; Pogany, G; Sasvári-Székely, M; Soóki-Tóth, A; Spasokukotskaja, T; Staub, M1
Creasia, D; Hoover, KL; Mikol, YB; Poirier, LA; Shivapurkar, N; Wilson, MJ1
Bapiro, TE; Bramhall, JL; Cook, N; Courtin, A; Frese, KK; Griffiths, JR; Jodrell, DI; Madhu, B; Neesse, A; Richards, FM; Tuveson, DA1
Chen, TC; Lin, G; Lin, KJ; Wang, F; Yeh, TS; Yen, TC1

Other Studies

4 other study(ies) available for choline and deoxycytidine

ArticleYear
Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. II. Ara-C does not inhibit the later process in lymphoid cells.
    Biochemical and biophysical research communications, 1989, Sep-15, Volume: 163, Issue:2

    Topics: AraC Transcription Factor; Bacterial Proteins; Choline; Cytarabine; Deoxycytidine; DNA; Humans; Infant; Lymphoid Tissue; Lymphoma; Phospholipids; Repressor Proteins; Thymidine; Transcription Factors; Tumor Cells, Cultured

1989
Hepatic DNA methylation and liver tumor formation in male C3H mice fed methionine- and choline-deficient diets.
    Journal of the National Cancer Institute, 1986, Volume: 77, Issue:1

    Topics: Animals; Body Weight; Choline; Deoxycytidine; Diet; Diethylnitrosamine; DNA; Liver; Liver Neoplasms; Male; Methionine; Methylation; Mice; Mice, Inbred C3H; Organ Size; S-Adenosylhomocysteine; S-Adenosylmethionine; Time Factors

1986
Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.
    British journal of cancer, 2014, Jul-15, Volume: 111, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Choline; Deoxycytidine; Diphosphates; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Tumor Cells, Cultured

2014
Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
    Disease models & mechanisms, 2018, 05-14, Volume: 11, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Choline; Choline Kinase; Deoxycytidine; Drug Synergism; Everolimus; Fluorodeoxyglucose F18; Gemcitabine; Humans; Male; Metabolome; Mice; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2018